Biogen (BIIB) PT Lowered to $350 at Oppenheimer
Get Alerts BIIB Hot Sheet
Price: $209.15 -0.32%
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 8 | New: 6
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 8 | New: 6
Join SI Premium – FREE
Oppenheimer analyst Jay Olson lowered the price target on Biogen (NASDAQ: BIIB) to $350.00 (from $390.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Wolfe Research Upgrades Biogen (BIIB) to Outperform
- Citi Downgrades Northern Star Resources (NST:AU) (NESRF) to Neutral
- Citi Downgrades JB Hi-Fi Ltd (JBH:AU) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share